5 June 2026

Improved treatment satisfaction with once-weekly IcoSema versus once-daily glargine U100 in insulin-naive adults with T2D (COMBINE 4)

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

Diabetes

Congress poster

Amylin

IcoSema (Icodec Semaglutide)

PHASE 3 (RCT)